Fairmount Funds Management LLC - 06 Mar 2025 SCHEDULE 13D/A Report for ORUKA THERAPEUTICS, INC. Common Stock, $0.001 par value (ORKA)

Filing Manager
Fairmount Funds Management LLC
Reporting Manager
Fairmount Funds Management LLC
Security
ORUKA THERAPEUTICS, INC. Common Stock, $0.001 par value
Symbol
ORKA
Shares outstanding
42,580,410 shares
Disclosed Ownership
8,511,824 shares
Ownership
20%
Form type
SCHEDULE 13D/A
Filing time
10 Mar 2025, 19:00:37 UTC
Date of event
06 Mar 2025
Next filing
19 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Fairmount Funds Management LLC disclosed 20% ownership in ORUKA THERAPEUTICS, INC. Common Stock, $0.001 par value (ORKA) on 06 Mar 2025."

Quick Takeaways

  • Fairmount Funds Management LLC filed SCHEDULE 13D/A for ORUKA THERAPEUTICS, INC. Common Stock, $0.001 par value (ORKA).
  • Disclosed ownership: 20%.
  • Date of event: 06 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Mar 2025, 19:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Fairmount Funds Management LLC 20% 8,511,824 0 8,511,824 /s/ Peter Harwin Peter Harwin, Managing Member 0001802528
Fairmount Healthcare Fund II L.P. 14% 5,938,516 0 5,938,516 /s/ Peter Harwin Peter Harwin, Managing Member 0001769651
Fairmount Healthcare Co-Invest III L.P. 6.9% 2,573,308 0 2,573,308 /s/ Peter Harwin Peter Harwin, Managing Member 0002009690
Peter Evan Harwin 20% 8,511,824 0 8,511,824 /s/ Peter Harwin Peter Harwin 0001663607
Tomas Kiselak 20% 8,511,824 0 8,511,824 /s/ Tomas Kiselak Tomas Kiselak 0001830177

Sponsored